We previously reported the strategy for the construction of antibodies against CXADR and the preliminary results of their anti-tumor effects in EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics10. This evidence concerns the gene CXADR and neoplasm.